carbidopa has been researched along with Bradykinesia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Bloem, BR; Boel, JA; de Bie, RMA; de Haan, RJ; Deuschl, G; Dijk, JM; Dijkgraaf, MGW; Frequin, HL; Lang, A; Munts, AG; Post, B; Schouten, J; Suwijn, SR; Tissingh, G; van Hilten, JJ; van Laar, T; Verschuur, CVM | 1 |
Awad, N; Roy, D; Song, J; Zamudio, P | 1 |
Hattori, N; Ishiguro, Y; Kawajiri, S; Noda, K; Okuma, Y; Tomizawa, Y; Tosaka, Y | 1 |
Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY | 1 |
Antenor, J; Black, KJ; Burkey, A; Esper, GJ; Kotagal, V; Moerlein, SM; Ojemann, JG; Perlmutter, JS; Racette, BA; Videen, TO | 1 |
Bakay, RA; Corcos, DM; Metman, LV; Prodoehl, J; Sturman, MM; Vaillancourt, DE | 1 |
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
2 trial(s) available for carbidopa and Bradykinesia
Article | Year |
---|---|
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
Topics: Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor | 2023 |
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor | 2003 |
5 other study(ies) available for carbidopa and Bradykinesia
Article | Year |
---|---|
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19.
Topics: Blood Coagulation; Brain Diseases; Carbidopa; Central Nervous System Stimulants; Cognitive Dysfunction; COVID-19; Critical Care; Drug Combinations; Humans; Hypokinesia; Ischemic Stroke; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Modafinil; Rehabilitation; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Ventilator Weaning | 2021 |
Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis.
Topics: Carbidopa; Chorea; Disease Progression; Dopamine Agonists; Drug Combinations; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Myelinolysis, Central Pontine; Parkinsonian Disorders | 2015 |
Pathophysiology of parkinsonism due to hydrocephalus.
Topics: Adult; Antiparkinson Agents; Brain Mapping; Carbidopa; Caudate Nucleus; Cerebral Ventricles; Drug Combinations; Equipment Failure; Humans; Hydrocephalus; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Neurologic Examination; Parkinsonian Disorders; Positron-Emission Tomography; Postoperative Complications; Putamen; Ventriculoperitoneal Shunt | 2004 |
Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease.
Topics: Ankle Joint; Antiparkinson Agents; Biomechanical Phenomena; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Electromyography; Humans; Hypokinesia; Isometric Contraction; Levodopa; Muscle Weakness; Muscle, Skeletal; Parkinson Disease; Reference Values; Signal Processing, Computer-Assisted; Statistics as Topic; Torque; Treatment Outcome; Tremor | 2006 |
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |